Probiotics Reports 17th May 2023

Market analysis for IBS-positioned probiotic supplements in 20 countries

€500

BUY THE REPORT

About the report

Published July 2018. There are between 140 and 580 million IBS sufferers, many undiagnosed, and within this group more than 220 million young women in need of nutritional support for IBS symptoms. A growing body of research backs probiotic and synbiotic supplements to offer real benefits to hundreds of millions of Irritable Bowel Syndrome (IBS) sufferers globally. This report examines online retailing, regulatory, marketing as well as scientific data and trends in 20 countries to pry open a niche but expanding sector bristling with business opportunity.

What this report tells you

  • The IBS relief landscape: Background, what countries and how many people are affected.
  • The evolution of probiotics as a mean to relieve IBS symptoms and what  populations new products could target.
  • Rising awareness of IBS in the context of the “Amazon age” and how new IBS-positioned products can flourish.
  • Special focus on countries with exciting opportunities for this niche: China, Australia, North America, Europe and South Africa. Includes case studies on existing products in these markets.
  • The prevalence of IBS claims on-pack and which countries lead on this.
  • Overview of strains: Which are dominant, which countries have largest strain diversity for IBS-positioned products, what species are used to tackle IBS-symptoms, breakdown of major probiotic suppliers and an examination of other probiotic blends.
  • Conclusion and recommendations.
  • Appendix of studies relating to the relief of IBS symptoms.

Report Chapters

  • Global picture
  • Country & strain focus:
    • China
    • Australia
    • North America
    • Europe
    • South Africa
  • IBS claims and science

Quick facts:

  • There are between 140 and 580 million IBS sufferers, many undiagnosed, and there is a pool of 220 million young women in need of nutritional support for IBS symptoms.
  • Direct and indirect costs to society include reduction of physical activity, lost work productivity and absenteeism, increased prevalence of anxiety and mood disorders, as well as social stigmas and societal alienation.
  • The difficulty in diagnosing IBS is a global challenge. The devastating effect IBS has on people’s lives could be significantly reduced with more rapid, accurate diagnosis and treatment. The Internet is key to speeding up this process.
  • Although not conclusive, a significant body of research has found that single and multiple strain probiotic supplementation, as well as synbiotic supplementation, can be effective in offering relief for most IBS symptoms.
  • 11 of the surveyed countries feature IBS-positioned probiotic supplements, with none in big markets like the US, Brazil, nor mainland China.

Market analysis for IBS-positioned probiotic supplements in 20 countries

€500

BUY THE REPORT